SCYNEXIS Stock

SCYNEXIS Profit per Employee

The Profit per Employee of SCYNEXIS (SCYX) as of Aug 12, 2026 is -788,444.44 USD. In the previous year, Profit per Employee was 2.48 M USD — a change of -131.75% (lower).

Profit per Employee

-788,444.44USD

YoY

-131.75%

Last updated:

Profit per Employee of SCYNEXIS is 2026 -788,444.44 USD. Profit per Employee of SCYNEXIS was 2025 2.48 M USD. It decreases by -131.75% lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Profit per Employee of SCYNEXIS is -788,444.44 USD in 2026.

Profit per Employee of SCYNEXIS changed from 2.48 M USD to -788,444.44 USD, representing a -131.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's SCYNEXIS historically and in real time.

Access this data via the Eulerpool API

Workforce — SCYNEXIS

All Key Metrics — SCYNEXIS